Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Acquisitions (2016 - 2025)

Historic Acquisitions for Resmed (RSMDF) over the last 16 years, with Q3 2025 value amounting to $522000.0.

  • Resmed's Acquisitions fell 3894.74% to $522000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $139.1 million, marking a year-over-year increase of 47240.44%. This contributed to the annual value of $140.1 million for FY2025, which is 396.71% up from last year.
  • Per Resmed's latest filing, its Acquisitions stood at $522000.0 for Q3 2025, which was down 3894.74% from $138.6 million recorded in Q2 2025.
  • In the past 5 years, Resmed's Acquisitions ranged from a high of $992.1 million in Q4 2022 and a low of $522000.0 during Q3 2025
  • For the 5-year period, Resmed's Acquisitions averaged around $91.8 million, with its median value being $8.4 million (2021).
  • In the last 5 years, Resmed's Acquisitions soared by 266242.52% in 2022 and then plummeted by 9924.35% in 2023.
  • Resmed's Acquisitions (Quarter) stood at $35.9 million in 2021, then surged by 2662.43% to $992.1 million in 2022, then plummeted by 99.24% to $7.5 million in 2023, then crashed by 91.07% to $670000.0 in 2024, then dropped by 22.09% to $522000.0 in 2025.
  • Its last three reported values are $522000.0 in Q3 2025, $138.6 million for Q2 2025, and $670000.0 during Q4 2024.